Results 11 to 20 of about 44,322 (189)
Mitochondrial cardiomyopathies [PDF]
Frontiers in Cardiovascular Medicine, 2016 Mitochondria are found in all nucleated human cells and perform a variety of essential functions, including the generation of cellular energy. Mitochondria are under dual genome control.
Ayman W. El-Hattab, Fernando Scaglia
doaj +4 more sources
Cardiomyopathies: Temporal Review and Genetic Determination [PDF]
BiomedicinesCardiomyopathies are a heterogeneous group of diseases of the myocardium associated with dysfunction, with or without a structural substrate. They are frequently genetically determined. The dysfunction may be mechanical, both of the systole and diastole,
Gaetano Thiene +2 more
doaj +3 more sources
Survival of patients with cardiomyopathies [PDF]
Българска кардиология, 2021 Cardiomyopathies are a heterogeneous group of diseases. The main pathogenetic mechanism is myocardial damage due to genetic mutations. Cardiomyopathies are one of the leading causes of heart failure, sudden cardiac death, and life-threatening arrhythmias.
Monika Shumkova +4 more
doaj +4 more sources
Clinical Medicine Insights: Cardiology, 2015 Infiltrative cardiomyopathies can result from a wide spectrum of both inherited and acquired conditions with varying systemic manifestations. They portend an adverse prognosis, with only a few exceptions (ie, glycogen storage disease), where early ...
David Bejar +3 more
doaj +3 more sources
Overview of Cardiomyopathies in Childhood
Frontiers in Pediatrics, 2021 Paediatric cardiomyopathies are a heterogenous group of rare disorders, characterised by mechanical and electrical abnormalities of the heart muscle. The overall annual incidence of childhood cardiomyopathies is estimated at about 1 per 100,000 children ...
Anika Rath +3 more
doaj +3 more sources
ICD Outcome in Pediatric Cardiomyopathies
Journal of Cardiovascular Development and Disease, 2022 Background: Pediatric patients with cardiomyopathies are at risk of malignant arrhythmias and sudden cardiac death (SCD). An ICD may prevent SCD. The aim of this study was to evaluate ICD implantation outcomes, and to compare transvenous and subcutaneous
Massimo Stefano Silvetti +10 more
doaj +2 more sources
Clinical genetic aspects of cardiomyopathies
Journal of the Practice of Cardiovascular Sciences, 2015 Cardiomyopathies are a major cause of heart disease. Not only the patients, but also their families are severely burdened by these illnesses. In the past decade, studies revealed the heterogeneity of these diseases in terms of clinical presentation, as ...
Mitali Kapoor +2 more
doaj +2 more sources
Inherited Cardiomyopathies: Genetics and Clinical Genetic Testing
Cardiovascular Innovations and Applications, 2017 Inherited cardiomyopathies are major causes of morbidity and mortality and include a group of cardiac disorders such as hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), left ...
Guoliang Wang +4 more
doaj +3 more sources
Role of cardiac MRI in nonischemic cardiomyopathies
Indian Heart Journal, 2016 Cardiac magnetic resonance (CMR) with its higher spatial resolution is considered the gold standard for evaluating ventricular mass, volumes, and ejection fraction. CMR can be used for accurate diagnosis of several conditions, especially cardiomyopathies.
Senthil Anand, Rajesh Janardhanan
doaj +2 more sources
Clinical Medicine Insights: Cardiology, 2015 Cardiomyopathies (CMs) have many etiological factors that can result in severe structural and functional dysregulation. Fortunately, there are several potentially reversible CMs that are known to improve when the root etiological factor is addressed.
Harsh Patel +4 more
doaj +3 more sources